ANGPTL4 and breast cancer: In obesity-driven breast cancer, NLRC4 inflammasome activation in tumor-infiltrating macrophages enhances ANGPTL4 expression in mammary adipocytes via IL-1β, thereby driving tumor progression and angiogenesis [13].